| Sleep Apnea, Obstructive
Zepbound vs Nuvigil
Side-by-side clinical, coverage, and cost comparison for sleep apnea, obstructive.Deep comparison between: Zepbound vs Nuvigil with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsNuvigil has a higher rate of injection site reactions vs Zepbound based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Nuvigil but not Zepbound, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Zepbound
Nuvigil
At A Glance
SC injection
Once weekly
GIP/GLP-1 receptor agonist
Oral
Once daily
Wakefulness-promoting agent
Indications
- Obesity
- Sleep Apnea, Obstructive
- Sleep Apnea, Obstructive
- Narcolepsy
- Shift work disorder
Dosing
Obesity Starting dose 2.5 mg SC once weekly for 4 weeks, escalating in 2.5 mg increments every 4 weeks; maintenance 5 mg, 10 mg, or 15 mg SC once weekly.
Sleep Apnea, Obstructive Starting dose 2.5 mg SC once weekly for 4 weeks, escalating in 2.5 mg increments every 4 weeks; maintenance 10 mg or 15 mg SC once weekly.
Sleep Apnea, Obstructive, Narcolepsy 150 mg to 250 mg taken orally once daily as a single dose in the morning.
Shift work disorder 150 mg taken orally once daily as a single dose approximately 1 hour prior to the start of the work shift.
Contraindications
- Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Known serious hypersensitivity to tirzepatide or any excipient in ZEPBOUND
- Known hypersensitivity to modafinil or armodafinil or its inactive ingredients
Adverse Reactions
Most common (>=2%) Nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, eructation, hair loss, gastroesophageal reflux disease, flatulence, abdominal distension, dizziness
Serious Risk of thyroid C-cell tumors, severe gastrointestinal reactions, acute kidney injury, acute gallbladder disease, acute pancreatitis, hypersensitivity reactions including anaphylaxis and angioedema, hypoglycemia, diabetic retinopathy complications, pulmonary aspiration
Postmarketing Acute pancreatitis, hemorrhagic and necrotizing pancreatitis, ileus, intestinal obstruction, severe constipation including fecal impaction, anaphylaxis, angioedema, pulmonary aspiration, acute renal failure or worsening of chronic renal failure
Most common (>=5%) Headache, nausea, dizziness, insomnia
Serious Serious dermatologic reactions, DRESS/multiorgan hypersensitivity, angioedema and anaphylaxis, persistent sleepiness, psychiatric symptoms, cardiovascular events
Postmarketing Mouth sores (including mouth blistering and ulceration)
Pharmacology
Tirzepatide is a dual GIP receptor and GLP-1 receptor agonist that selectively binds and activates both receptors, reducing body weight by decreasing caloric intake and affecting appetite regulation, stimulating glucose-dependent insulin secretion, reducing glucagon secretion, and delaying gastric emptying.
Armodafinil is a wakefulness-promoting agent and indirect dopamine receptor agonist that binds to the dopamine transporter and inhibits dopamine reuptake, with wake-promoting actions similar to sympathomimetic agents, although its precise mechanism is unknown.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Zepbound
- Covered on 5 commercial plans
- PA (9/12) · Step Therapy (0/12) · Qty limit (9/12)
Nuvigil
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (10/12) · Qty limit (10/12)
UnitedHealthcare
Zepbound
- Covered on 4 commercial plans
- PA (5/8) · Step Therapy (4/8) · Qty limit (1/8)
Nuvigil
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Humana
Zepbound
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (1/3) · Qty limit (0/3)
Nuvigil
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (2/3) · Qty limit (3/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
$25/fillfill
Zepbound Savings Card - Covered benefitCommercial or private insurance
Medicare, Medicaid, VA, TRICARE
Final cost depends on formulary coverage
No savings programs available for Nuvigil.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
ZepboundView full Zepbound profile
NuvigilView full Nuvigil profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.